Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date Sort ascending
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Internal Medicine Japan
Efforts to Improve Quality of Migraine Medical Care
Release Date:
Partner: The Japanese Headache Society
Review Process: Expert Review Panel
Translation: Japanese (link)
Education Internal Medicine Japan
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Research Inflammation & Immunology China
Shared Decision-Making (SDM) in Lung Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Improving the Therapeutic Environment for Metastatic Breast Cancer
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Gene and Gene-modified Cell Therapies Medical Education
Release Date:
Partner: American Society of Gene + Cell Therapy
Review Process: Expert Review Panel
Education Rare Disease All
New Mechanisms and Emerging Treatment Options in Metastatic Breast Cancer
Release Date:
Partner: Arvinas
Review Process: Pfizer Internal
Education Oncology All
Sickle Cell Disease (SCD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Rare Disease USA
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
Review Process: Pfizer Internal
Education Health Equity China
Improving Care for Patients with Hodgkin and Non-Hodgkin’s Lymphoma
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date Sort ascending
Optimizing COVID-19 Treatment Strategies in Elderly Vulnerable Populations in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Vaccines Canada
Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
Review Process: Expert Review Panel
Quality Improvement Rare Disease All
Approaches to Improve Delivery of Quality of Care for Patients with Inflammatory, and Immune Skin Diseases
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology Japan
Patient Education and Support for the Management of Migraine
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine All
Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism (ex-US)
Release Date:
Partner: Bristol-Myers Squibb
Review Process: Pfizer Internal
Education Internal Medicine All
Accord for a Healthier World: Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
Release Date:
Review Process: Pfizer Internal
Quality Improvement Hospital Malawi, Rwanda, Senegal
PARP-inhibitor Combination Treatments in Prostate Cancer, a Global Perspective
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Non-Muscle Invasive Bladder Cancer Emerging Markets Needs Assessment
Release Date:
Review Process: Pfizer Internal
Education Oncology Argentina, Brazil, Colombia, Hong Kong, India, Mexico, Saudi Arabia, Taiwan, Turkey, United Arab Emirates
Improving Education Disparities of Non-Specialized Health Care Providers to Deliver Appropriate Medical Care for IBD Patients
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology Argentina, Brazil, India, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates
Improving Early Detection and Appropriate Anticoagulant Therapy for Atrial Fibrillation
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
Improving access to and the quality of clinical diagnostic solutions (Africa Geographic Scope)
Release Date:
Review Process: Pfizer Internal
Quality Improvement Support for the Professions All
Evidence-informed treatment decisions in chronic inflammatory disorders
Release Date:
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology Australia